Open Access. Powered by Scholars. Published by Universities.®

Law Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 30 of 37

Full-Text Articles in Law

Getting The Haves To Come Out Behind: Fixing The Distributive Injustices Of American Health Care, David A. Hyman Oct 2006

Getting The Haves To Come Out Behind: Fixing The Distributive Injustices Of American Health Care, David A. Hyman

Law and Contemporary Problems

Hyman criticizes an article by Havighurst and Richman regarding the distributive injustices of US health care. Hyman also offers a guide for implementing policy reforms based on the analysis by Havighurst and Richman.


Journal Staff Oct 2006

Journal Staff

Law and Contemporary Problems

No abstract provided.


The Impact Of Tax-Exempt Status: The Supply-Side Subsidies, Richard L. Schmalbeck Oct 2006

The Impact Of Tax-Exempt Status: The Supply-Side Subsidies, Richard L. Schmalbeck

Law and Contemporary Problems

Schmalbeck provides some background and history of the tax rules governing health care institutions and assess the significance of the subsidies these tax rules create.


Distributional Considerations In The Overregulation Of Health Professionals, Health Facilities, And Health Plans, Christopher J. Conover Oct 2006

Distributional Considerations In The Overregulation Of Health Professionals, Health Facilities, And Health Plans, Christopher J. Conover

Law and Contemporary Problems

Conover addresses the equity issue in health care spending. Conover concludes that the marginal impact of health regulation is to make the US health system more, rather than less, regressive.


Overregulation Of Health Care: Musings On Disruptive Innovation Theory, Lesley H. Curtis Ph.D., Kevin A. Schulman M.D. Oct 2006

Overregulation Of Health Care: Musings On Disruptive Innovation Theory, Lesley H. Curtis Ph.D., Kevin A. Schulman M.D.

Law and Contemporary Problems

Disruptive innovation theory provides one lens through which to describe how regulations may stifle innovation and increase costs. Basing their discussion on this theory, Curtis and Schulman consider some of the effects that regulatory controls may have on innovation in the health sector.


Of Head Taxes, Income Taxes, And Distributive Justice In American Health Care, Lawrence Zelenak Oct 2006

Of Head Taxes, Income Taxes, And Distributive Justice In American Health Care, Lawrence Zelenak

Law and Contemporary Problems

Havighurst and Richman have made an important contribution by uncovering ways in which the current system of health care financing, including the income-tax treatment of employer-provided health insurance, has disturbing distributional effects.


Distributive Injustice(S) In American Health Care, Clark C. Havighurst, Barak D. Richman Oct 2006

Distributive Injustice(S) In American Health Care, Clark C. Havighurst, Barak D. Richman

Law and Contemporary Problems

Havighurst and Richman seek to show the nature--and to suggest the cumulative attitude--of the many regressive tendencies of the financing, regulatory and legal regime governing the private side of US health care.


Paying For What You Get And Getting What You Pay For: Legal Responses To Consumer-Driven Health Care, Mark A. Hall Oct 2006

Paying For What You Get And Getting What You Pay For: Legal Responses To Consumer-Driven Health Care, Mark A. Hall

Law and Contemporary Problems

No abstract provided.


Distributive Justice In Pharmaceutical Torts: Justice Where Justice Is Due?, Chen-Sen Wu M.D., J.D. Oct 2006

Distributive Justice In Pharmaceutical Torts: Justice Where Justice Is Due?, Chen-Sen Wu M.D., J.D.

Law and Contemporary Problems

Chen-Sen Wu concludes that, until empirical evidence clarifies the net distributive impact of pharmaceutical torts, the capacity for tort reform to rectify distributive injustices in health care will remain far from obvious.


The Political Economy Of Unfairness In U.S. Health Policy, Jonathan Oberlander Oct 2006

The Political Economy Of Unfairness In U.S. Health Policy, Jonathan Oberlander

Law and Contemporary Problems

Oberlander discusses the political economy of unfairness in US health policy by first highlighting the moral issues raised by the US's system of financing medical care and then by analyzing the political dynamics that sustain that system.


Measuring Distributive Injustice On A Different Scale, Tom Miller Oct 2006

Measuring Distributive Injustice On A Different Scale, Tom Miller

Law and Contemporary Problems

Miller highlights the importance of education as a powerful contributor to significant differences in health outcomes. Enhancing educational opportunities for lower-income Americans may help to ensure that only no child, but also no patient, is left behind.


Foreword: Health Policy’S Fourth Dimension, Clark C. Havighurst, Barak Richman Oct 2006

Foreword: Health Policy’S Fourth Dimension, Clark C. Havighurst, Barak Richman

Law and Contemporary Problems

No abstract provided.


The Tax Subsidy To Employment-Based Health Insurance And The Distribution Of Well-Being, Mark Pauly Oct 2006

The Tax Subsidy To Employment-Based Health Insurance And The Distribution Of Well-Being, Mark Pauly

Law and Contemporary Problems

Pauly considers some recent contrasting views on the distributional effects of the tax subsidy within employment groups. He shows that the correct answer depends on what one assumes to be the within-group incidence of the reduction in money wages that occurs when group insurance is part of a competitive compensation package.


The Corrosive Combination Of Nonprofit Monopolies And U.S.-Style Health Insurance: Implications For Antitrust And Merger Policy, Barak D. Richman Oct 2006

The Corrosive Combination Of Nonprofit Monopolies And U.S.-Style Health Insurance: Implications For Antitrust And Merger Policy, Barak D. Richman

Law and Contemporary Problems

No abstract provided.


Why We Need Global Standards For Corporate Disclosure, Allen L. White Jul 2006

Why We Need Global Standards For Corporate Disclosure, Allen L. White

Law and Contemporary Problems

After two years of gradual revelations concerning undisclosed information on suicidal risks to children on antidepressants, a federal advisory committee in Sep 2004 recommended that such drugs be labeled to alert physicians and consumers of this risk. The antidepressant story is noteworthy in its own right, shedding light on the tangled web of legal, regulatory, economic, and ethical issues surrounding disclosure practices in the pharmaceutical industry. The complex interworkings of an emerging global economy make it necessary for corporate standards for disclosure to be established and enforced.


Foreword: Sarbanes-Oxley For Science, David Michaels Jul 2006

Foreword: Sarbanes-Oxley For Science, David Michaels

Law and Contemporary Problems

No abstract provided.


Sometimes The Silence Can Be Like The Thunder: Access To Pharmaceutical Data At The Fda, Peter Lurie, Allison Zieve Jul 2006

Sometimes The Silence Can Be Like The Thunder: Access To Pharmaceutical Data At The Fda, Peter Lurie, Allison Zieve

Law and Contemporary Problems

Those committed to the free exchange of scientific information have long complained about various restrictions on access to the FDA's pharmaceutical data and the resultant restrictions on open discourse. A review of open-government procedures and litigation at the FDA demonstrates that the need for transparency at the agency extend well beyond the reach of any clinical trial registry.


Public Health Versus Court-Sponsored Secrecy, Daniel J. Givelber, Anthony Robbins Jul 2006

Public Health Versus Court-Sponsored Secrecy, Daniel J. Givelber, Anthony Robbins

Law and Contemporary Problems

Public health practice relies on access to information. Givelber and Robbins discuss the debate about "court-sponsored" secrecy: Whether or not courts should tolerate, edorse, or protect secrecy when the sequestered information might help protect the public health.


The People’S Agent: Executive Branch Secrecy And Accountability In An Age Of Terrorism, Sidney A. Shapiro, Rena I. Steinzor Jul 2006

The People’S Agent: Executive Branch Secrecy And Accountability In An Age Of Terrorism, Sidney A. Shapiro, Rena I. Steinzor

Law and Contemporary Problems

Shapiro and Steinzor apply the agency theory to the question of how much secrecy is too much. They use the theory to evaluate the impact of burgeoning secrecy in the likelihood that the executive branch officials will engage in faithful and forceful implementation of statutory materials, particularly in the arenas of protecting public health, safety, and natural resources.


Scientific Secrecy And “Spin”: The Sad, Sleazy Saga Of The Trials Of Remune, Susan Haack Jul 2006

Scientific Secrecy And “Spin”: The Sad, Sleazy Saga Of The Trials Of Remune, Susan Haack

Law and Contemporary Problems

Haack sketches an account of what science is and does that suggests how and why the ways in which scientific work is funded can distort or even block its progress. She puts her theory to work by analyzing the troubled history of the trials--clinical and legal--of Immune Response's AIDS drug, Remune.


Transparency And Innuendo: An Alternative To Reactive Over-Disclosure, Scott M. Lassman Jul 2006

Transparency And Innuendo: An Alternative To Reactive Over-Disclosure, Scott M. Lassman

Law and Contemporary Problems

Lassman examines the tension between transparency and other public health interests in the context of the FDA's proposed Drug Watch web site. He argues that although the FDA proposal seeks to achieve a laudable goal--the prompt communication of important useful safety information about drug products to physicians and patients-- it fails to properly balance transparency and other legitimate public health interests.


Open Secrets: The Widespread Availability Of Information About The Health And Environmental Effects Of Chemicals, James W. Conrad Jr. Jul 2006

Open Secrets: The Widespread Availability Of Information About The Health And Environmental Effects Of Chemicals, James W. Conrad Jr.

Law and Contemporary Problems

Conrad discusses the point of view of the chemical industry concerning when and how access to health effects information may be affected by financial interests. He argues that no qualitative distinction can be drawn between the financial and other incentives that might affect disclosure by for-profit entities and the incentives that might affect disclosure by other entities that may conduct, sponsor, or opine on scientific research.


Journal Staff Jul 2006

Journal Staff

Law and Contemporary Problems

No abstract provided.


Transparency In Public Science: Purposes, Reasons, Limits, Sheila Jasonoff Jul 2006

Transparency In Public Science: Purposes, Reasons, Limits, Sheila Jasonoff

Law and Contemporary Problems

No abstract provided.


Memoriam Apr 2006

Memoriam

Law and Contemporary Problems

Professor Shimm was a native of New York City, graduated with honors in 1947 from Columbia University after a hiatus of three years serving in the Army in World War II and emerging as a Lieutenant in the Field Artillery. He attended Yale Law School, again graduating with honors, in 1950. He practiced law privately in New York City from 1950 to 1951 and was an attorney for the Wage Stabilization Board in Washington, D.C., from 1951 to 1952. He first taught law as a Bigelow Fellow at the University of Chicago in 1952 and came to Duke Law School …


Revisiting The Legal Link Between Genetics And Crime, Deborah W. Denno Apr 2006

Revisiting The Legal Link Between Genetics And Crime, Deborah W. Denno

Law and Contemporary Problems

In 1994, convicted murderer Stephen Mobley became a cause celebre when he appealed his death sentence before the Georgia Supreme Court in the case of Mobley v. State. Denno describes the potential implications arising from the high-profile case of Stephen Mobley. He sought to introduce a then-cutting-edge theory that violence could be based on a genetic or neurochemical abnormality as mitigating evidence during capital sentencing.


Considering Convergence: A Policy Dialogue About Behavioral Genetics, Neuroscience, And Law, Brent Garland, Mark S. Frankel Apr 2006

Considering Convergence: A Policy Dialogue About Behavioral Genetics, Neuroscience, And Law, Brent Garland, Mark S. Frankel

Law and Contemporary Problems

Garland and Frankel issue a call for scientists, lawyers, courts and lawmakers to begin a critical dialogue about the implications of scientific discoveries and technological advances in criminal law, behavioral genetics and neuroscience.


Behavioral Genetics Research And Criminal Dna Databases, D. H. Kaye Apr 2006

Behavioral Genetics Research And Criminal Dna Databases, D. H. Kaye

Law and Contemporary Problems

Kaye discusses DNA databanks and the potential use of such databanks for behavioral genetics research. He addresses the concern that DNA databanks serve as a limitless repository for future research and that the samples used in the databanks could be used for research into a crime gene.


Genetic Predictions Of Future Dangerousness: Is There A Blueprint For Violence?, Erica Beecher-Monas, Edgar Garcia-Rill Apr 2006

Genetic Predictions Of Future Dangerousness: Is There A Blueprint For Violence?, Erica Beecher-Monas, Edgar Garcia-Rill

Law and Contemporary Problems

Beecher-Monas and Garcia-Rill consider the unfortunate probability that behavioral genetics evidence will be misused to substantiate predictions of future dangerousness.


The Scarlet Gene: Behavioral Genetics, Criminal Law, And Racial And Ethnic Stigma, Karen Rothenberg, Alice Wang Apr 2006

The Scarlet Gene: Behavioral Genetics, Criminal Law, And Racial And Ethnic Stigma, Karen Rothenberg, Alice Wang

Law and Contemporary Problems

Rothenberg and Wang discuss the broader social implications of researching traits of interest to the criminal law. They consider the social impact for those who participate in behavioral genetics studies, particularly when such research focuses on behaviors related to conduct such as addiction.